Navigation Links
International training to assist governments of 5 African nations in detecting poor-quality drugs
Date:4/18/2011

Rockville, Md., April 18, 2011 Scientists from the national laboratories of five African nations are gathering in Accra, Ghana, this week to take part in technical training that will provide them with improved capacity to detect substandard and counterfeit medicines. The trainingwhich will include participants from Ethiopia, Ghana, Kenya, Senegal and Sierra Leoneis part of a larger Technical Assistance Program (TAP) announced earlier this year and funded by the U.S. Pharmacopeial Convention (USP), a nonprofit public health organization that sets standards for the identity, quality, purity and strength of prescription and over-the-counter medicines.

Under TAPwhich is currently a pilot program involving the five sub-Saharan African countries and Egypt but may be expanded in scopeUSP is providing a comprehensive package of pharmaceutical reference standards (very pure physical samples used as reference chemicals to test medicines), documentary standards (written specifications) and technical training to assist these countries in improving the quality of their medicines. Constrained by limited resources, the national laboratories in these nations may resort to using unreliable or outdated standards, and/or may not be equipped to offer their analysts the scientific training required to appropriately analyze medicines. As such, these laboratories may not obtain accurate results when they test questionable samplesa serious gap in quality assurance that can lead to severe health outcomes for patients, including prolonged disease and death. The USP-sponsored training being conducted this week will focus on three key topics necessary to appropriately test medicines qualityFundamentals of High Performance Liquid Chromatography, Microbiology and Effectively Using USPNF (USP's drug compendia).

In all of the participating nations, poor-quality medicines represent a significant public health challenge. In the host country of Ghana, for instance, a recent World Health Organization study found that 39 percent of tested antimalarial medicines failed quality testingfor reasons that include insufficient amounts of the active pharmaceutical ingredient (a serious problem that can lead to the rise in drug-resistant disease parasites) and excess levels of problematic impurities.

"With inferior medicines threatening the lives of citizens every day in Africa, it is essential for governments to be equipped with the tools necessary to accurately gauge the quality of the medicines circulating in their markets. Having a team of scientists trained in essential analytical techniques is a fundamental aspect of a well-functioning regulatory system that protects the domestic drug supply," said Patrick Lukulay, Ph.D., director of the Promoting the Quality of Medicines (PQM) Program, a USP-U.S. Agency for International Development (USAID) program that works in more than 30 countries to help ensure the quality, safety and efficacy of medicines to treat diseases such as malaria and tuberculosis. TAP is a USP initiative that makes USP standards available to promote drug quality in developing countries by leveraging resources toward a common goal.

"As Ghana makes strides to address the devastation caused by substandard or fake medications, we are very pleased to host a delegation of countries seeking to do the same," said Stephen Opuni, M.D., chief executive officer of the Ghana Food and Drugs Board. "This training will enhance our ability to detect such 'medicines,' which can cause as much harm as a disease itself."

The objectives of this week's training are to 1) improve the technical competence of the scientists; 2) familiarize participants with information contained in the USPNF and how to utilize the information to effectively perform quality control analysis; and 3) improve capacity and effectiveness of participating laboratories to identify poor-quality and counterfeit medicines.

The training was driven by the needs of the attending countries, with USP developing the program based on feedback from participants about the technical topics they wanted to see addressed.

For more information, please email mediarelations@usp.org.


'/>"/>

Contact: Francine Pierson
fp@usp.org
301-816-8588
US Pharmacopeia
Source:Eurekalert

Related medicine news :

1. International Diabetes Federation awards $2 million to 9 global diabetes research projects
2. Jion Beijing Great Wall International Travel Agency Immediate Exposure to China Expo 2010
3. H1N1 international symposium to be hosted by Emory-UGA Influenza Center
4. International Insurance Group, Inc. Releases First Quarter 2010 Newsletters
5. Partners Harvard Medical International Set to Play Key Role as Saudi Arabia Pursues Ambitious Health Care Transformation
6. The Hawaii Nurses Association Announces Affiliation with the Office and Professional Employees International Union, AFL-CIO
7. Reno Children With Disabilities Profit From a Little Known but Internationally Recognized Non-Profit Organization as it Quietly Crosses the $200,000.00 Mark in Service Investment Into the Reno Area
8. Tyco International Announces Exchange Rate for Quarterly Dividend
9. International Merchant Advisors Inc. to Open New Wellness Centers With Medical Marijuana Treatment Facilities
10. SRI International Expands Neurosciences Research with New Neurodegenerative Diseases Research Program
11. International study confirms doubling of childhood leukemia rates in southern Iraq
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... ... 2017 , ... HMP , a leader in healthcare events and education, today ... Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & ... award competition recognizes editorial and design excellence across a range of sectors. This year’s ...
(Date:10/12/2017)... Wesley Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... Chapel is holding a treadmill relay – Miles by Moonlight to raise money for ... by donating $300 or more. , Teams will work together to keep their ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
(Date:9/19/2017)... Ky. , Sept. 19, 2017   ZirMed Inc ... predictive analytics, today announced that it has been ranked #1 ... Black Book™ Rankings 2017 User Survey. ZirMed was ... solution for large hospitals and medical centers over 200 beds ... Black Book,s healthcare technology user survey history. ...
(Date:9/12/2017)... MOUNTAIN LAKES, N.J. , Sept. 12, 2017  Consumer reviews ... Embrace Hearing as the number one company for hearing ... Oticon™, ReSound™ and fifteen other brands. ... Embrace Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that ...
Breaking Medicine Technology: